SK08

SK08活菌散

Report date: 2026/03/27 20:01:50

Base Information

Drug NameSK08
Drug Alias NameSK-08
ClassificationBiologics > Live Biotherapeutic
Mechanisms of ActionGastrointestinal microbiome modulatorsBacteria replacements
TargetsNot applicable
Therapy Area/IndicationsSolid tumoursDiarrheaIrritable Bowel Syndrome +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesGuangzhou Zhiyi Biological Technology Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesGuangzhou Zhiyi Biological Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursDiarrheaIrritable Bowel Syndrome +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A